NAGE - NASDAQ

NB

Niagen Bioscience Inc

NAGE·NASDAQ

$3.50

-1.1%
HealthcareBiotechnology

Niagen Bioscience Inc is a bioscience company dedicated to healthy aging. The Company leads research on nicotinamide adenine dinucleotide.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$278.76M
EPS0.2200
P/E Ratio15.91
Earnings Date08/05/2026

nage

Other Current Liabilities

Last Annual Value

8.12M

3-Year CAGR

%

5-Year CAGR

%

10-Year CAGR

70%

NB

Niagen Bioscience Inc Competitors Analysis of Other Current Liabilities

NAGE · NASDAQ
CompanyOther Current Liabilities
CAGR 3Y
CAGR 5Y
CAGR 10Y
NAGE logo
Niagen Bioscience Inc
NASDAQ:NAGE
8.12M
N/AN/A59.5% 
PRTA logo
Prothena Corporation plc
NASDAQ:PRTA
29.42M
140.0%135.6%31.7%
AKBA logo
Akebia Therapeutics, Inc.
NASDAQ:AKBA
101.67M
77.2%26.7%126.2%
VTYX logo
Ventyx Biosciences, Inc.
NASDAQ:VTYX
0.00
N/AN/AN/A
KROS logo
Keros Therapeutics, Inc.
NASDAQ:KROS
16.04M
15.6%44.1%N/A
RGNX logo
REGENXBIO Inc.
NASDAQ:RGNX
38.39M
-23.6%-7.8%23.1%
OLMA logo
Olema Pharmaceuticals, Inc.
NASDAQ:OLMA
32.02M
80.3%51.9%N/A
CRVS logo
Corvus Pharmaceuticals, Inc.
NASDAQ:CRVS
5.84M
84.6%24.3%5.2%
KALV logo
KalVista Pharmaceuticals, Inc.
NASDAQ:KALV
36.80M
106.0%60.0%37.9%
RIGL logo
Rigel Pharmaceuticals, Inc.
NASDAQ:RIGL
61.62M
71.0%20.6%26.2%
ZVRA logo
Zevra Therapeutics, Inc.
NASDAQ:ZVRA
22.67M
28.0%94.2%88.0%
NB

Niagen Bioscience Inc Fair Value Envelope

NAGE · NASDAQ

Our analysis suggests that NAGE has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $3.5, this represents a potential HIDDEN relative to our calculated worth for Niagen Bioscience Inc.

HIDDEN
Intrinsic Value
Current Price: $3.5

Related Guides

Blog Categories

Continue your NAGE research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.